Lee Kenzie, Kourelis Taxiarchis, Tschautscher Marcella, Warsame Rahma, Buadi Francis, Gertz Morie, Muchtar Eli, Dingli David, Hayman Suzanne, Go Ronald, Hwa Lisa, Fonder Amie, Gonsalves Wilson, Hobbs Miriam, Kyle Robert, Kapoor Prashant, Leung Nelson, Binder Moritz, Cook Joselle, Lin Yi, Rogers Michelle, Rajkumar S Vincent, Kumar Shaji, Dispenzieri Angela
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Leukemia. 2025 Mar;39(3):703-709. doi: 10.1038/s41375-024-02489-z. Epub 2024 Dec 16.
Cause of death (COD) in POEMS (polyneuropathy, organomegaly, endocrinopathies, monoclonal protein and skin changes) syndrome is not well described. We investigated COD in patients with POEMS syndrome treated at Mayo Clinic between 2000 and 2022. Of the 89 deaths, 49 patients had known COD and were the subject of this study. Seventeen patients died of unrelated causes, while 32 patients (65%) died from causes related to POEMS syndrome including secondary malignancies like myelodysplastic syndrome and acute leukemia (n = 5) and complications from active therapy (n = 5). Notably, 19 patients died with a stereotypic syndrome we termed capillary leak phenotype (CLP), which was characterized by refractory ascites, effusions and/or anasarca that ultimately resulted in hypotension, renal failure and cardiopulmonary arrest. Alternate causes for these symptoms, such as cardiac and hepatic etiologies, were excluded. CLP as a COD was an earlier event with a median time from diagnosis to death of 2.5 years compared to 12.0 years for all other deceased patients (p = <0.0001). By definition, treatment of terminal CLP was unsuccessful with median survival of only 4 months after CLP onset. The driver of CLP is unknown, but recognition as an entity should allow for systematic study.
POEMS(多发性神经病、器官肿大、内分泌病、单克隆蛋白血症和皮肤改变)综合征的死因尚无详尽描述。我们调查了2000年至2022年在梅奥诊所接受治疗的POEMS综合征患者的死因。在89例死亡病例中,49例患者死因明确,为本研究对象。17例患者死于无关原因,而32例患者(65%)死于与POEMS综合征相关的原因,包括继发性恶性肿瘤,如骨髓增生异常综合征和急性白血病(n = 5)以及积极治疗的并发症(n = 5)。值得注意的是,19例患者死于一种我们称为毛细血管渗漏表型(CLP)的典型综合征,其特征为难治性腹水、积液和/或全身性水肿,最终导致低血压、肾衰竭和心肺骤停。排除了这些症状的其他原因,如心脏和肝脏病因。CLP作为死因是一个较早发生的事件,从诊断到死亡的中位时间为2.5年,而所有其他死亡患者为12.0年(p = <0.0001)。根据定义,终末期CLP的治疗未成功,CLP发作后的中位生存期仅为4个月。CLP的驱动因素尚不清楚,但将其识别为一种实体应有助于进行系统研究。